colorectal%20cancer
COLORECTAL CANCER
Colorectal cancer is a carcinoma arising from the luminal surface of the colon.
It is the 2nd most common cancer in women and third most common cancer in male worldwide. It commonly arises from adenomatous polyps.
It is strongly linked to age with 83% occurring in people ≥60 years old.
Rectal cancer is defined as cancerous lesions located within 12 cm of the anal verge.

Monitoring

Colorectal Screening

  • Primary goals are colorectal cancer prevention & early detection
  • Substantially reduces mortality rates in individuals between the age of 50 to 70 year 
  • May either be done among high-risk groups (eg those with IBD or with adenomatous polyps) or to the general population
  • No single screening test is 100% sensitive
  • Screening IBD patients helps detect colorectal cancer at an earlier stage but does not reduce mortality from colorectal cancer

Screening for the General Population

  • Colonoscopy
    • Best screening modality for high risk patients & best follow-up strategy for evaluating patients with positive gFOBT
    • Only screening test shown to reduce the incidence of colorectal cancer among screened individuals
    • Advantages include its wide availability, it allows single-session diagnosis & treatment, ability to examine entire colon, comfortable when done with sedation, & is the only test recommended at 10-year intervals
    • Interval for colonoscopy depends on factors such as family history of colorectal cancer (esp in 1st-degree relatives <50 years old), age at colitis diagnosis, presence of primary sclerosing cholangitis (PSC) & severity of inflammation
  • Flexible sigmoidoscopy
    • Recommended direct visualization test used for the detection of adenomatous polyps & carcinoma
    • Studies have shown that this test helps reduce mortality risk from CRC
    • Disadvantage for this procedure includes colonic perforations & bleeding
  • Guaiac-based fecal occult blood testing (gFOBT)
    • Shown by several studies to reduce mortality from CRC 
    • A negative result does not ensure that patient is free from colorectal cancer
  • Fecal immunochemical testing (FIT)
    • Has higher detection rates for advanced adenomas & cancer compared to gFOBT
  • Fecal immunochemical testing-Deoxyribonucleic Acid (FIT-DNA)
    • An emerging screening test that uses FIT to detect DNA biomarkers in stool samples
  • Chromoendoscopy with dye-spraying
    • Yields higher results in detecting dysplasia compared with standard white-light endoscopy
    • Use of indigo carmine dye, although more costly, is preferred over methylene blue (as the former does not induce DNA damage)
  • Computed Tomography Colonography (Virtual Colonoscopy/CTC)
    • A non-invasive technique that may be used to detect polyps or carcinomas >10 mm in size
    • Not suitable for detecting lateral spread & polyps measuring <1 cm

Screening based on Risk Stratification

  • Individuals at average risk
    • Recommended at age ≥50 years (≥45 years of age for African Americans or American Indians)
    • Colonoscopy is the preferred screening modality & may be done every 10 years
    • If colonoscopy is incomplete, repeat colonoscopy should be considered or other screening methods (eg double-contrast barium enema) in a shorter interval
    • Other recommended screening tests include annual fecal-based tests (ie gFOBT, FIT, FIT-DNA), flexible sigmoidoscopy every 5 years
  • Individuals at increased risk
    • Following screening colonoscopy & complete polypectomy:
      • Low-risk adenomas (≤2 tubular adenomas measuring <1 cm): 1st follow-up colonoscopy within 5 years, if normal, repeat every 5-10 years
      • Advanced/multiple adenomas (3-10 polyps measuring ≥10 mm & with any villous features or high-grade dysplasia): Repeat colonoscopy within 3 years; subsequent colonoscopies within 5 years, or depending on findings
      • Polypectomy of large sessile polyps (associated with high rate of recurrence): Follow-up colonoscopy within 2-6 months

Screening for Special Population

  • Obese people
    • Screening should be initiated as early as 45 years of age
  • Smokers
    • Based on various studies, screening is recommended among active smokers & those with >20 pack-years of smoking
    • Screen as early as 45 years of age, esp for those with >20 pack-years of smoking

Screening for Patients with Inflammatory Bowel Disease

  • Colonoscopy should be done in all ulcerative colitis & Crohn’s colitis patients every 1-2 years & should be started 8-10 years after onset of symptoms or when in remission
  • Strictures (esp in ulcerative colitis) should be assessed thoroughly through biopsy & brush cytology
  • When deemed appropriate, endoscopic polypectomy with biopsies of surrounding mucosa are done to check for dysplasia

Screening for Patients with Personal History of Colorectal Cancer

  • Colonoscopy 1 year post-operatively (within 3-6 months if preoperative colonoscopy is incomplete)
    • If normal, this is repeated in 2-3 years then every 5 years
    • If sessile serrated polyps (SSP) or adenomas are found, colonoscopy is done in 1-3 years
    • Subsequent colonoscopic intervals will vary among patients but should not exceed 5 years
  • For patients with rectal cancer, rigid or flexible sigmoidoscopy of the rectal anastomosis should be done in addition to colonoscopy
    • Repeat every 3-6 months for the 1st 2-3 years

Screening for Individuals with Positive Family History of Colorectal Cancer

  • Individuals with 1st-degree relative (FDR) with colorectal cancer diagnosed at age <60 years or individuals with 2 1st-degree relatives diagnosed with colorectal cancer at any age
    • Colonoscopy beginning at age 40 & repeated every 5 years
  • Individuals with 1st-degree relative (FDR) with colorectal cancer diagnosed at age ≥60 years
    • Colonoscopy beginning at age 50 & repeated every 5 years; if positive, may repeat according to colonoscopy results

Screening for Patients After Surgical Removal of Adenomatous Polyps

  • Risk of colorectal cancer is increased in patients with ≥3 adenomas measuring >1 cm at 1st colonoscopy or those with villous or high-grade dysplastic component
  • Low-risk patients are those with 1 or 2 adenomas <1 cm without villous or high-grade dysplastic features & may not require colonoscopic surveillance
    • However, colonoscopy may be performed at 5 years if other factors are present (eg family history)
  • Patients with either one adenoma measuring >1 cm in size or 3-4 small adenomas <1 cm are considered intermediate risk & surveillance colonoscopy is recommended every 3 years
  • Presence of ≥5 small adenomas or ≥3 adenomas, with at least one measuring ≥1 cm in size, patient is high risk & should have colonoscopy yearly
  • Surveillance colonoscopy is not recommended to continue beyond 75 years of age

Prevention

Colorectal Cancer Prevention

Diet

  • Regarded as the most important acquired factor in colorectal cancer
  • Diets rich in fiber may help reduce the risk for colorectal cancer
  • Calcium salts & calcium-rich foods may have protective role in colorectal cancer since they decrease colon cell turnover & reduce the cancer-promoting effects of fatty acids & bile acids
  • Consumption of red meat should be limited to <500 g (18 oz) per week but processed food should be avoided

Weight management

  • Maintain body mass index (BMI) near the lower limit of the normal range

Physical Activity

  • Adults should aim to have at least 2.5 hours of moderate intensity exercise (eg brisk walking) a week or 30 minutes on at least 5 days a week

Alcohol

  • Should be limited to no more than 2 drinks per day (30 g of ethanol or 4 units) for men & one drink per day (15 g of ethanol or 2 units) for women

Smoking

  • Patients should be discouraged from smoking or, for smokers, encouraged to quit smoking

Follow Up

  • Detecting relapse in advance is the main goal
    • Rise in carcinoembryonic antigen level is usually the first signal of recurrence & is most effective in patients without elevation preoperatively
  • Colorectal cancer surveillance include:
    • History, physical examination every 3-6 months for 2 years, then every 6 months for a total of 5 years
    • CEA test at baseline, then every 3-6 months for 2 years, then every 6 months for a total of 5 years if cancer is potentially resectable for isolated metastases
    • Colonoscopy at 1 year post-resection or every 3-6 months after resection if not done preoperatively due to an obstructing lesion; repeat at 3 years, then every 5 years thereafter
      • If follow-up colonoscopy reveals advanced adenoma, repeat colonoscopy in 1 year
      • More frequently done if colorectal cancer presented before 50 years of age
      • Important also in identifying & removing metachronous polyps, especially in the first 2 years after resection
    • CT scan of the chest, abdomen & pelvis yearly for 5 years among stage II & III patients
      •  Consider every 6-12 months for the first 3 years in patients who are at higher risk of recurrence
      •  Important in monitoring potentially resectable metastases
    •  Endoscopic surveillance for patients who underwent endoscopic removal of polyps with invasive cancer should be individualized
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 4 days ago
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
Yesterday
Breast cancer patients have notably different microbiomes in the local breast tissue and urinary tract, a recent study reveals. Particularly, species in the Methylobacterium genus are reduced in the local breast tissue while the urinary tract is enriched in gram-positive bacteria.
Pearl Toh, 13 Oct 2017
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.
14 Oct 2017
In pregnant women, adherence to recommended dietary intake of fat and fibre is associated with a more beneficial and richer gut microbiota which, in turn, decreases levels of the inflammation marker glycoprotein acetylation (GlycA), a study has shown.